ArticleDiabetes research and clinical practice2025

Risk of lower extremity complications with GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors in peripheral artery disease.

Alexander T Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.